<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>ModernaTx Inc — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/modernatx-inc</link>
    <description>Plain-English explanations of patents assigned to ModernaTx Inc, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Sun, 12 Jul 2026 13:20:34 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/modernatx-inc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Moderna&apos;s mRNA Vaccine Technology Targets Betacoronaviruses</title>
      <link>https://patentbrief.org/patent/us/10702600/betacoronavirus-mrna-vaccine</link>
      <description>A patent describing a specific mRNA vaccine design that uses lipid nanoparticles to deliver genetic instructions for building parts of a betacoronavirus to trigger an immune response.</description>
      <pubDate>Tue, 07 Jul 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/10702600/betacoronavirus-mrna-vaccine</guid>
    </item>
  </channel>
</rss>
